Edition:
India

People: Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

3.62USD
3 Aug 2020
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$3.62
Open
$3.48
Day's High
$3.63
Day's Low
$3.43
Volume
842,470
Avg. Vol
1,464,127
52-wk High
$7.10
52-wk Low
$1.97

Hutson, Nancy 

Dr. Nancy J. Hutson Ph.D. is Independent Directors of Endo International Public Limited Company., since 2009 . She has been a member of the Board of Directors since February 2014 and is Chair of Endo’s Compliance Committee and a member of Endo’s Nominating & Governance Committee. Dr. Hutson retired from Pfizer, Inc. (Pfizer) in 2006 after spending 25 years in various research and leadership positions, most recently having served as Senior Vice President, Pfizer Global Research and Development and Director of Pfizer’s pharmaceutical R&D site, known as Groton/New London Laboratories. At Pfizer, she led 4,500 colleagues (primarily scientists) and managed a budget in excess of $1 billion. She is currently a Director of BioCryst Pharmaceuticals, Inc. and PhaseBio Pharmaceuticals, Inc. Dr. Huston previously served as Director of Cubist Pharmaceuticals until 2015 and Inspire Pharmaceuticals, Inc. until 2011. From 2009 until February 2014, Dr. Hutson was a Director of Endo Health Solutions Inc. Dr. Hutson owns and operates Standing Stones Farm in Ledyard, CT. Dr. Hutson holds a Bachelor of Arts degree from Illinois Wesleyan University and a Ph.D. degree from Vanderbilt University. Dr. Hutson’s qualifications to serve on the Board of Endo include, among others, her in-depth knowledge and understanding of the complex research, drug development and business issues facing pharmaceutical companies.

Basic Compensation

Total Annual Compensation, USD 80,000
Restricted Stock Award, USD 240,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 320,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --